Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review

References

• Wikiversity. Role of the immune system – [online] [cited 2019 July 16]. Available from: https://en.wikiversity.org/wiki/Role_of_the_immune_system 2019.
   Google Scholar
• Ngo S, Steyn F, McCombe P. Gender differences in autoimmune disease. Front Neuroendocrinol. 2014;35(3):347–69. doi: 10.1016/j.yfrne.2014.04.004
   PubMed Web of Science ®Google Scholar
• Evans C, Beland SG, Kulaga S. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195–210. doi: 10.1159/000342779
   PubMed Web of Science ®Google Scholar
• GBD Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16(11):877–97. doi: 10.1016/S1474-4422(17)30299-5
   PubMed Web of Science ®Google Scholar
• Multiple Sclerosis International Federation. Atlas of MS 2013; mapping multiple sclerosis around the world 2013; Available from: https://www.msif.org/about-us/who-we-are-and-what-we-do/advocacy/atlas/.
   Google Scholar
• Gaby A. Multiple sclerosis. Global Adv Health Med. 2013;2(1):50–6. doi: 10.7453/gahmj.2013.2.1.009
   PubMedGoogle Scholar
• Selmi C, Cincinelli G, Generali E, Dudam R, Ravindran V. Why women or why not men? Sex and autoimmune diseases. Ind J Rheumatol. 2018;13(1):44–50. doi: 10.4103/injr.injr_1_18
   Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626–38. doi: 10.1038/nri.2016.90
   PubMed Web of Science ®Google Scholar
• Mahad D, Trapp B, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183–93. doi: 10.1016/S1474-4422(14)70256-X
   PubMed Web of Science ®Google Scholar
• Alkasir R, Li J, Li X, Jin M, Zhu B. Human gut microbiota: the links with dementia development. Protein Cell. 2016;8:90–102. doi: 10.1007/s13238-016-0338-6
   PubMed Web of Science ®Google Scholar
• Hu X, Wang T, Jin F. Alzheimer’s disease and gut microbiota. Life Sci. 2016;59:1006–23. doi: 10.1007/s11427-016-5083-9
   Web of Science ®Google Scholar
• Saresella M, Mendozzi L, Rossi V, Mazzali F, Piancone F, La Rosa F, et al. Immunological and clinical effect of diet modulation of the gut microbiome in multiple sclerosis patients: a pilot study. Front Immunol. 2017;8:1391–402. doi: 10.3389/fimmu.2017.01391
   PubMed Web of Science ®Google Scholar
• La Rosa F, Clerici M, Ratto D, Occhinegro A, Licito A, Romeo M, et al. The gut-brain axis in Alzheimer's disease and omega-3. A critical overview of clinical trials. Nutrients. 2018;10:1267–84. doi: 10.3390/nu10091267
   Web of Science ®Google Scholar
• Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1):1–20. doi: 10.1177/1759091414568185
   Web of Science ®Google Scholar
• Bagur M, Murcia M, Jiménez-Monreal A, Tur J, Bibiloni M, Alonso G, et al. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr. 2017;8(3):463–72. doi: 10.3945/an.116.014191
   PubMed Web of Science ®Google Scholar
• Katz Sand I. The role of diet in multiple sclerosis: mechanistic connections and current evidence. Curr Nutr Rep. 2018;7(3):150–60. doi: 10.1007/s13668-018-0236-z
   PubMedGoogle Scholar
• Jahromi S, Toghae M, Jahromi M, Aloosh M. Dietary pattern and risk of multiple sclerosis. Iran J Neurol. 2012;11(2):47–53.
   PubMedGoogle Scholar
• Sedaghat F, Jessri M, Behrooz M, Mirghotbi M, Rashidkhani B. Mediterranean diet adherence and risk of multiple sclerosis: a case-control study. Asia Pac J Clin Nutr. 2016;25(2):377–84.
   PubMed Web of Science ®Google Scholar
• Lucinda JB, Kimberley B, Anne-Louise P, Ingrid M, Robyn ML, Gavin P, et al. A higher mediterranean diet score, including unprocessed red meat, is associated with reduced risk of central nervous system demyelination in a case-control study of Australian adults. J Nutr. 2019: nxz089. doi:10.1093/jn/nxz089.
   Web of Science ®Google Scholar
• Gan R, Young K, Zerbe G, Demoruelle M, Weisman M, Buckner J, et al. Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study. Rheumatology. 2015;55(2):367–76. doi: 10.1093/rheumatology/kev266
   PubMed Web of Science ®Google Scholar
• Calder P. Omega-3: the good oil. Nut Bulletin. 2017;42(2):132–40. doi: 10.1111/nbu.12261
   Web of Science ®Google Scholar
• Badsha H. Role of diet in influencing rheumatoid arthritis disease activity. Open Rheumatol J. 2018;12(1):19–28. doi: 10.2174/1874312901812010019
   PubMedGoogle Scholar
• Hidaka BH, Li S, Harve KE, Carlson SE, Sullivan DK, Kimler BF, et al. Omega-3 and omega-6 fatty acids in blood and breast tissue of high-risk women and association with atypical cytomorphology. Cancer Prev Res. 2015;8(5):359–64. doi: 10.1158/1940-6207.CAPR-14-0351
   PubMed Web of Science ®Google Scholar
• Edwards I, O'Flaherty J. Omega-3 fatty acids and PPARγ in cancer. PPAR Res. 2008: 1–14. doi: 10.1155/2008/358052
   Web of Science ®Google Scholar
• Jelinek G, Hadgkiss E, Weiland T, Pereira N, Marck C, van der Meer D. Association of fish consumption and omega-3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis. Int J Neurosci. 2013;123(11):792–801. doi: 10.3109/00207454.2013.803104
   PubMed Web of Science ®Google Scholar
• Ramirez-Ramirez V, Macias-Islas M, Ortiz G, Pacheco-Moises F, Torres-Sanchez E, Sorto-Gomez T, et al. Efficacy of fish oil on serum of TNFα, IL-1β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid Med Cell Longev. 2013: 1–8. doi: 10.1155/2013/709493
   Web of Science ®Google Scholar
• Navarini L, Afeltra A, Gallo Afflitto G, Margiotta DPE. Polyunsaturated fatty acids: any role in rheumatoid arthritis? Lipids Health Dis. 2017;16(1):197. doi: 10.1186/s12944-017-0586-3
   PubMedGoogle Scholar
• Sorto-Gomez ET, Ortiz GG, Fermín P, Pacheco-Moises F, Torres-Sánchez E, Ramirez-Ramirez V, et al. Effect of fish oil on glutathione redox system in multiple sclerosis. Am J Neurodegener Dis. 2016;5(2):145–51.
   PubMedGoogle Scholar
• Polman CH, Reingold CS, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. doi: 10.1002/ana.22366
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston DAS, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for MS: guidelines from the international panel on the diagnosis of MS. Ann Neurol. 2001;50(1):121–27. doi: 10.1002/ana.1032
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Ann Neurol. 2005;58(6):840–46. doi: 10.1002/ana.20703
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73. doi: 10.1016/S1474-4422(17)30470-2
   PubMed Web of Science ®Google Scholar
• Shamliyan T, Kane RL, Dickinson S. A systematic review of tools used to assess the quality of observational studies that examine incidence or prevalence and risk factors for diseases. J Clin Epidemiol. 2010;63:1061–70. doi: 10.1016/j.jclinepi.2010.04.014
   PubMed Web of Science ®Google Scholar
• Shamliyan T, Kane RL, Jansen S. Quality of systematic reviews of observational nontherapeutic studies. Prev Chronic Dis. 2010b;7:A133.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. Br Med J. 2011;343:d5928. doi: 10.1136/bmj.d5928
   PubMed Web of Science ®Google Scholar
• Woodward M. Sample size determination. In: Chapman & Hall, editor. Epidemiology: study design and data analysis. 2nd ed. London: CRC; 2005. p. 295–326.
   Google Scholar
• Whitley E, Ball J. Statistics review 4: sample size calculations. Crit Care. 2002;6:335–41. doi: 10.1186/cc1521
   PubMed Web of Science ®Google Scholar
• Williams JW, Plassman BL, Burke J, Benjamin S. Preventing Alzheimer’s disease and cognitive decline. Evid Rep Technol Assess (Full Rep). 2010;193:1–72.
   Google Scholar
• Shinto L, Marracci G, Baldauf-Wagner S, Strehlow A, Yadav V, Stuber L, et al. Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins. Leukot Essent Fatty Acids. 2009;80(2–3):131–36. doi: 10.1016/j.plefa.2008.12.001
   PubMed Web of Science ®Google Scholar
• Pantzaris M, Loukaides G, Ntzani E, Patrikios I. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomized, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open. 2013;3(4):e002170. doi: 10.1136/bmjopen-2012-002170
   PubMed Web of Science ®Google Scholar
• Bjørnevik K, Chitnis T, Ascherio A, Munger K. Polyunsaturated fatty acids and the risk of multiple sclerosis. Mult Scler. 2017;23(14):1830–38. doi: 10.1177/1352458517691150
   PubMed Web of Science ®Google Scholar
• Zandi-Esfahan S, Fazeli M, Shaygannejad V, Hasheminia J, Badihian S, Aghayerashti M, et al. Evaluating the effect of adding fish oil to Fingolimod on TNF-α, IL1β, IL6, and IFN-γ in patients with relapsing-remitting multiple sclerosis: A double-blind randomized placebo-controlled trial. Clin Neurol Neurosurg. 2017;163:173–78. doi: 10.1016/j.clineuro.2017.10.004
   PubMed Web of Science ®Google Scholar
• Wergeland S, Torkildsen Ø, Bø L, Myhr KM. Polyunsaturated fatty acids in multiple sclerosis therapy. Acta Neurol Scand Suppl. 2012;195:70–5. doi: 10.1111/ane.12034
   PubMedGoogle Scholar
• Cunnane S, Ho S, Dore-Duffy P, Ells K, Horrobin D. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr. 1989;50(4):801–6. doi: 10.1093/ajcn/50.4.801
   PubMed Web of Science ®Google Scholar